BeOne Sciences

BeOne Sciences is a San Diego-based biotechnology company dedicated to the discovery and development of first-in-class small molecule therapeutics for oncology. The company's research focuses on a novel, proprietary target designated as B1, which plays a critical role in the survival and proliferation of various cancer types. By inhibiting this target, BeOne Sciences aims to overcome resistance mechanisms and provide new treatment options for patients with difficult-to-treat solid tumors and blood cancers. The company is currently advancing its lead programs through pre-clinical development, leveraging deep expertise in medicinal chemistry and cancer biology. BeOne Sciences operates with a mission to deliver precision medicines that can significantly improve outcomes for patients facing aggressive malignancies.